|

Fluzoparib Monotherapy Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Tongji Hospital1
  • Tianjin Medical University Cancer Institute and Hospital1

Indications

  • Cancer2
  • BRCA1/2 Mutation or Not1
  • Platinum-sensitive1
  • TNBC - Triple-Negative Breast Cancer1
  • Ovarian Cancer1

Other2 trials

A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance
Phase 2
Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.